Trial Profile
Pharmacokinetics of lisdexamfetamine capsules administered intranasally versus orally in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Oct 2009
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary) ; Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacokinetics
- Sponsors Shire
- 30 Oct 2009 New trial record.
- 22 Oct 2009 Results were reported in a Shire media release.